Galvus Met is a medication used to treat type 2 diabetes. It combines two active ingredients: vildagliptin and metformin. Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which works by increasing the levels of incretin hormones in the body, leading to increased insulin release and decreased glucagon secretion. Metformin is a biguanide that helps to lower blood sugar levels by decreasing glucose production in the liver and improving insulin sensitivity in the muscles.
Galvus Met is typically prescribed along with diet and exercise to help control blood sugar levels in patients with type 2 diabetes. It is available in various strengths and formulations, including tablets that can be taken once or twice daily. As with any medication, Galvus Met may cause side effects, such as nausea, diarrhea, stomach upset, and headache. It’s important for patients to discuss the potential benefits and risks of Galvus Met with their healthcare provider before starting treatment.
